Stoke Therapeutics (STOK) Income Statement: Revenue & Earnings

Stoke Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Stoke Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	36.56	8.78	12.41	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	36.56	8.78	12.41	0.00	0.00
Operating Expenses
Research & Development	89.13	82.23	77.84	54.17	32.20
Selling, General & Administrative	48.79	41.32	38.92	31.90	20.85
Operating Expenses	137.93	123.55	116.76	86.07	53.04
Operating Income	-101.37	-114.77	-104.36	-86.07	-53.04
Other Income/Expense
Interest Income	0.00	9.91	3.12	0.12	0.70
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	12.39	0.17	0.17	0.14	-0.10
Income
Income Before Tax	-88.98	-104.70	-101.07	-85.81	-52.24
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-88.98	-104.70	-101.07	-85.81	-52.24
Net Income - Continuous Operations	-88.98	-104.70	-101.07	-85.81	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-99.20	-112.30	-102.81	-85.09	-52.16
EBIT	-88.96	-114.77	-104.36	-86.07	-53.04
Depreciation & Amortization	2.18	2.47	1.55	0.97	0.90
Earnings Per Share
Basic EPS	-2.00	-2.00	-3.00	-2.00	-2.00
Diluted EPS	-2.00	-2.00	-3.00	-2.00	-2.00
Basic Shares Outstanding	54.01	43.99	38.90	36.74	33.49
Diluted Shares Outstanding	54.01	43.99	38.90	36.74	33.49